Contact
About Abbott
cardiovascular
MY ACCOUNT

Vessel Closure

Vessel Closure

Haemostasis Management Solutions

Abbott is committed to providing haemostasis management solutions to help patients and hospitals thrive. Time management, patient and staff flow, hospital costs, and throughput can all impact overall hospital efficiency.

Our haemostasis management portfolio aims to drive hospital efficiency through:

  • Early ambulation1-4
  • Reducing patient length of stay1-4
  • Lowering access site-related complications1,3,4
  • Improving patient outcomes2,5

 

  • Optimising nursing time1,3,4
  • Driving overall hospital efficiency1,3,4
  • Improving patient flow1,3,4

Vascular Closure Systems
 

Perclose™ ProStyle™ Suture-Mediated Closure and Repair (SMCR) System6

  • The Perclose™ ProStyle™ Suture-Mediated Closure and Repair (SMCR) System is the next generation design evolution of the proven and trusted Perclose ProGlide™ SMC System.
  • Similar to the Perclose ProGlide™ device, each Perclose™ ProStyle™ device delivers the same secure, non-masking percutaneous suture to the access site that promotes primary intention healing7 and has no reaccess restrictions.6
  • The updated Perclose™ ProStyle™ SMCR System has been designed with features such as high-tensile strength needles for more reliability in complex and challenging anatomies, additional visual cues for a more intuitive deployment experience, and the addition of our popular Perclose™ Snared Knot Pusher which offers a more tactile and tapered knot advancement.8
Perclose ProStyle

StarClose SE™ Vascular Closure System (VCS)9

  • StarClose SE™ Vascular Closure System can be utilised after arterial access procedures using 5-6F introducer sheaths and provides safe10, easy and extravascular percutaneous closure for diagnostic or interventional procedures.
StarClose SE™ Vascular Closure System (VCS)

Compression Assist Devices
 

FemoStop™ Femoral Compression Systems11

The FemoStop™ Compression Assist Device uses hands-free compression of the femoral artery or vein to offer precise haemostasis management and patient comfort.

  • The adjustable belt fits securely so that small patient movements may not cause the device to slip and patients can rest comfortably
  • Hands-free compression
    • Allows multiple patients to be monitored at one time, increasing staff efficiency
    • Minimises staff exposure to blood and reduces neck, arm and wrist fatigue
Femostop Gold
Explore Abbott's technologies for your needs.

Explore Abbott's technologies for your needs.

Access personalised education and training

Access personalised education and training

How can we help? Reach Abbott’s fast support here.

How can we help? Reach Abbott’s fast support here.

References

  1. Fabbricatore D et al. (2023) Ambulatory PV isolation workflow using suture-mediated vascular closure devices: a prospective observational cohort study. (PRO-PVI Study). Europace. 25(4):1361-1368

  2. The Use of the Perclose ProGlide Suture Mediated Closure (SMC) Device for Venous Access-Site Closure up to 24F Sheaths. Kar, Saibal; Hermiller, James; et al. CRT 2018.

  3. Feasibility and Safety of Same Day Discharge for Patients Undergoing Atrial Fibrillation (AF) Ablation in a Community Hospital Setting. HRS 2020 Poster.

  4. Verma S. Same-Day Discharge for AF Ablation: What Have We Learned - EP Lab Digest - August 2020.

  5. Perclose ProGlide Versus Surgical Closure Outcomes - Real World Evidence. Schneider, Darren B; Krajcer, Zvonimir; et al. LINC 2018

  6. Perclose™ ProStyle™ SMCR System - Instructions for Use (IFU). Refer to IFU for additional information.

  7. Primary intention healing occurs where vessel wall edges are brought together, adjacent to each other. This can be achieved with sutures and other methods. Advances in Skin & Wound Care: Healing by Intention. Salcido, Richard. 2017.

  8. Data on file at Abbott.

  9. StarClose SE™ VCS System - Instructions for Use (IFU). Refer to IFU for additional information.

  10. Burke et al. StarClose Vascular Closure System (VCS) is Safe and Effective in Patients Who Ambulate Early Following Successful Femoral Artery Access Closure - Results from the RISE Clinical Trial. CCI 2012, 80:45-52.

  11. FemoStop™ II Plus Femoral Compression System - Instructions for Use (IFU). Refer to IFU for additional information.

MAT-2409380 v1.0

POLICIES
LOGIN & REGISTRATION
Abbott logo

Information contained herein for distribution in Australia and New Zealand only.
CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.
Abbott Vascular division of Abbott Medical New Zealand Ltd, Grd Flr, Bldg. D, 4 Pacific Rise Mt Wellington, Auckland 1060 Tel: 0800 827 285
Abbott Vascular division of Abbott Medical Australia Pty Ltd, 299 Lane Cove Road, Macquarie Park NSW 2113, Tel: 1800 550 939
© 2025 Abbott. All Rights Reserved.
MAT-2105201 v7.0

Disclaimer

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

 

Do you wish to continue and enter this website?

MAT-2105201 v1.0

Disclaimer

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

 

Do you wish to continue and enter this website?

MAT-2105201 v1.0